Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose response studies: how do we make them conclusive?

A Källén1, P Larsson

  • 1Astra Draco AB, Lund, Sweden.

Statistics in Medicine
|April 16, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The lipid paradox is also present in early axial spondyloarthritis: results from the Swedish part of the SPondyloArthritis Caught Early (SPACE) cohort.

Scandinavian journal of rheumatology·2024
Same author

Scanning laser-induced endothelial injury: a standardized and reproducible thrombosis model for intravital microscopy.

Scientific reports·2022
Same author

RECOMMENDATIONS FOR USE AND SCORING OF ORAL HEALTH IMPACT PROFILE VERSIONS.

The journal of evidence-based dental practice·2022
Same author

Biomechanical analysis of a new 8-strand technique for flexor tendon repair.

Hand surgery & rehabilitation·2020
Same author

Exhaled particles and small airways.

Respiratory research·2019
Same author

Predator evasion in Daphnia: the adaptive value of aggregation associated with attack abatement.

Oecologia·2017
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

This study argues that minimal effective dose is not clinically meaningful. Dose response studies should instead focus on drug potency relative to active controls, with analysis methods discussed.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Biostatistics

Background:

  • Dose-response studies are crucial in drug development.
  • Current interpretations of minimal effective dose lack clinical relevance.
  • Need for a more meaningful approach to analyzing dose-response data.

Purpose of the Study:

  • To redefine the meaningful use of dose-response studies.
  • To advocate for drug potency assessment relative to active controls.
  • To explore effective analytical strategies for dose-response data.

Main Methods:

  • Critique of the minimal effective dose concept.
  • Proposal for using active controls for potency comparison.
  • Discussion of various statistical analysis techniques.

Related Experiment Videos

Main Results:

  • Minimal effective dose is clinically insignificant.
  • Drug potency relative to active controls is a more meaningful endpoint.
  • Multiple analytical approaches can be employed.

Conclusions:

  • Rethinking the interpretation of dose-response studies is necessary.
  • Focusing on drug potency against active controls offers greater clinical utility.
  • Appropriate statistical analysis enhances the value of dose-response data.